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Structure-function relationships of any complex underlie the molecular details of the 
biological interactions. Rheb, Ras Homology Enriched in Brain, is a Ras-related protein, and it is 
genetically identified as a molecular switch. Rheb is regulated by cycling between the 
biologically active GTP and inactive GDP-bound forms. This regulation is partially controlled by 
an interaction with Tuberous Sclerosis Complex2 (TSC2), a GTPase activating protein (GAP). 
Upon interaction, TSC2 stimulates Rheb GTP hydrolysis and diminishes the mammalian target 
of rapamycin (mTOR) pathway. The mTOR pathway is involved in proteins synthesis, cell cycle, 
and signaling. Mutation in TSC2 causes abnormal activation of Rheb and affects the mTOR 
pathway signaling. However, the molecular details of this interaction are still largely 
unidentified. The goal of this project is to characterize the molecular features of TSC2-218-
N119K interaction by using biochemical and biophysical methods. The long-term objectives are 
to fill the gap in understanding TSC2-Rheb interaction, TSC2 GAP mechanism, and how that 
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 1.1 mTOR Pathway 
Organisms grow when cells receive proper signals for metabolic activity. In order to 
achieve balance between anabolism and catabolism processes, signals must be regulated to 
ensure that the cells perform their proper functions. Dysregulation of the signaling pathways 
leads to homeostasis disruption and disease occurrence. The mammalian serine/threonine protein 
kinase target of rapamycin mTOR pathway plays a significant role in cell synthesis, 
proliferation, and autophagy(1). Dysregulation of the mTOR pathway has been reported to cause 
several health issues such as cancer and metabolic diseases(2).  
There are two complexes in the mTOR pathway which are mTOR complex1 (mTORC1) 
and mTOR complex 2 (mTORC2) and each one of them integrates with different components 
and stimuli(1). The major components of mTROC1 are regulatory-associated proteins of mTOR 
(RAPTOR), and mammalian lethal with SEC thirteen 8 (mLST8)(1). Activation of mTORC1 
promotes protein synthesis and initiates translation by phosphorylating ribosomal protein S6 
(S6K1) and eIf4E-binding protein, respectively (4E-BP)(3,4). In addition, it enhances the pentose 
phosphate pathway genes expression and therefore increases 
5ʹ‑phosphoribosyl‑1’‑pyrophosphate (PRPP) production, which is the building block of purine 
and pyrimidine nucleotides(2). The mTORC1 pathway promotes lipogenesis through activation of 
the major regulators of lipid biosynthesis (SREBPs) and inhibition of the phosphatidic acid 
phosphatase that obstructs SREBPs function (LIPIN1)(2). Moreover, it controls autophagy, a 
process of cell destruction, through multiple ways including phosphorylation of UNC‑51‑like 
kinase1 that binds to 5' adenosine monophosphate -activated protein kinase and inhibits 






nutrients, growth factors or high cellular energy(6). These signals are transmitted to mTORC1 
through the regulation of a small G-protein called Rheb, which is a direct essential activator 
located upstream of mTORC1.     
1.2 Rheb 
Ras homology enriched in brain (Rheb) is a small GTPase protein that belongs to the Ras 
superfamily of G-proteins. The main function of Rheb is to control cell metabolism, growth, and 
proliferation through the mTORC1 cascade(7). Rheb is predominantly in an active state in the 
cell, unlike the most of Ras GTPases, because of Rheb’s low intrinsic GTPase activity and the 
small quantity TSC complex(8). The structure of Rheb exhibits high similarity, 30-40% sequence 
identity, to other Ras proteins(9). Rheb possess several characteristics that are different from other 
Ras proteins. For instance, during GTP/GDP exchange, Rheb switch II region retains a stable 
confirmation change whereas the long α-helical conformation occurs in Ras proteins(9). Rheb 
switch I region constitutes residues from 33 to 41 (resembles 30-80 residues of Ras), and switch 
II region constitutes residues from 63 to 79 (resembles 60-76 residues of Ras) (9). The existence 
of Gln64 in a deep hydrophobic core, instead of the surface like Gln61 in Ras proteins, makes it 
less accessible for GTP/GDP binding. Furthermore, unlike Tyr32 in Ras, the corresponding 
Tyr35 in Rheb shields the GTP phosphate moiety(9). Lastly, Rheb possess arginine and serine 
residues in its P-loop that bind to the beta domain of GDP or GTP, instead of glycine residues 
like other Ras proteins(10). Because of these differences, it has been suggested that Rheb has a 
unique GTPase mechanism. In fact, Asp65 in switch II and Thr38 in switch I are critical for 
Rheb GTP hydrolysis. However, Tyr35 residue in Rheb prevents the intrinsic GTPase catalytic 






Two mechanisms have been reported for activation of mTORC1 by Rheb. First, Liu et al. 
and Guo et al. claimed that peptidyl-prolyl-cis/trans-isomerase FKBP38 directly links Rheb to 
mTORC1. However, the findings of Wetzker et al. and Tang et al. studies contradict the 
previous claim(12–15). Therefore, the mechanism of mTORC1 activation remains controversial. 
Second, indirect stimulation by phosphatidic acid (PA) has been confirmed after treating 
HEK293 cells with PA and measuring the phosphate level of the downstream substrates of the 
mTORC1, S6K1 and 4E-BP(16). The active Rheb binds and activates phospholipase D1, which 
produces PA that can activate mTORC1(17). 
The activity of Rheb can be regulated by Guanine nucleotide Exchange Factors (GEFs) and 
GTPase Activating Proteins (GAPs) (Figure 1). GEFs induce the release of bound GDP to be 
replaced by GTP and, therefore, activate the downstream substrates. However, GAPs catalyze 
the hydrolysis of bound GTP to the GDP and thereby switch off the downstream pathway(8). The 
proteins that functions as GEFs are still unknown but the protein that acts as a GAP for Rheb is 
TSC2.  
 
Figure 1. Rheb GDP/GTP cycle. 
GEFs phosphorylate Rheb and GAPs 
stimulate GTP hydrolysis. Rheb-GDP 








The inhibition of TSC2 GAP activity occurs when the cells receive the growth factor 
signals. Structural studies show that these signals leads to the phosphorylation of TSC2 on 
ser939, ser981, ser1130, ser1132 and thr1462(1).  As a result, Rheb becomes permanently loaded 
with GTP and, therefore, activates the rest of the mTORC1 pathway(1). On the other hand, the 
absence of nutrients and the low energy level leads to the phosphorylation of TSC2 on ser1387 
and that promotes the GAP catalytic activity toward Rheb(3). Therefore, the now inactive GDP-
Rheb inhibits phosphorylation of the mTORC1 substrates and stops cell growth and synthesis 
(Figure 2)(3). 
TSC2 is active in a ternary complex with TSC1 and TBC1D7(18). Aberrant function and 
mutation in the TSC complex genes lead to a genetic disorder called tuberous sclerosis. TSC1 
encodes a protein called hamartin, 140-KD, and TSC2 encodes a protein called tuberin, 200-
KD(19). These proteins share little homology with each other and they bind to form a heterodimer 
with the recently discovered third subunit TBC1D7(20,18,21). The molecular function of TBC1D7 
is still unknown but it is hypothesized that it is required for GAP activity and that it stabilizes 
hamartin and tuberin dimerization and interaction(18,22). The TSC complex is located in multiple 
organs such as the brain, kidney, lung and pancreas(23). Previous studies have investigated the 
role of the TSC complex in the cell, primarily by studying these proteins in Drosophila 
melanogaster(24,25). One study showed that a TSC1/2 heterodimer mutation in drosophila 
increased cell size, and successive experiments indicated that the TSC1/2 complex interacts with 
several proteins leading to inhibition of the mammalian target of rapamycin pathway(24,25). On 
the other hand, phosphorylation on specific sites of TSC2 by protein kinase B (AKT) leads to the 






corresponding region in GAP proteins and hydrolyses Rheb. The resemblance of TSC2 C-
terminal to other GAP domains was first recognized when it was cloned in 1993. The C-terminal 
constitutes amino acid residues from 1517 to 1674 and it has a significant homology to human 
RAP1 GAP region(26). 
There have been several identified mutations in TSC2 in Tuberous Sclerosis patients(26). 
These mutations have been shown to occur in the GTPase activating region of the TSC2 
protein(27). The identification of the mutations and the study of protein interactions have shed 
light on TSC pathogenesis and have provided valuable information about the mTOR regulation. 
However, the mechanism of TSC2 GAP domain hydrolysis of Rheb is not completely 
understood. Characterizing the molecular details of TSC2 mutations in the GAP region should 
facilitate a greater understanding on the mechanism. The working hypothesis is that certain 
mutations on the TSC2 region will affect the Rheb interaction, and therefore alter the GTP 
hydrolysis, or show differences in its binding to Rheb.  
This project focuses on studying one mutation in the TSC2 gap catalytic domain, 
N1643K (Asn1643Lys) (Figure 3). This mutation was first discovered as a de novo mutation in a 
TSC patient in 1997 by Sampson et al(28). Our approach was to characterize the importance of 
the asparagine to lysine mutation on the structure-function relationship of TSC2 in its interaction 
with Rheb. Asparagine is a polar residue that is generally present on proteins’ surfaces(29), and its 
typically interacts with other polar amino acids via hydrogen bonding with peptide backbones 
and contributing to proteins binding. Moreover, asparagine is frequently found at the end of 
alpha helices, as highlighted in Figure 2.30. On the other hand, lysine is a positive charged 
residue that possess an ε-amino group, and hence this study characterizing the effect of the 






It is believed that TSC2 uses an asparagine-thumb mechanism, instead of an arginine 
finger like other Ras GAP proteins, to stimulate GTP hydrolysis of Rheb. This observation was 
derived from RAP1 asparagine-thumb mechanism and it was confirmed in previous studies(31,32). 
It is expected that this mutation will deactivate the TSC2 GAP activity and that deactivation 
could be due to loss of TSC2-Rheb binding or loss the GAP function. Another mutation that is 
located in the GAP binding domain is K1638A (Lys1638Ala), which has been investigated in Dr. 
Adams lab by a previous student. This K1638A mutation caused a weaker binding with Rheb, a 
loss of GAP activity and further resulted in Rheb remaining in a GTP-bound state (33). Therefore, 
this study implies that other mutations next to asparagine have influenced the thumb mechanism. 
Detailed work on how theses mutations impact the TSC2 GAP catalytic domain will reveal new 
information on the TSC disease.  
A small-truncated TSC2 with 218 amino acids has been used in this study to eliminate 
the challenges of the full TSC2 length, 1807 amino acids. In Quilliam et al., the TSC2-C 
terminus that contains the GAP binding regions (965-1807 amino acids) was cloned and proved 
its binding to Rheb in vitro(34). Marshall et al., have showed that TSC2 residues 1525 to 1742 
exhibits the highest expression and stability(32). Therefore, in this project, TSC2 1525-1742—
called TSC2-218—have been used to investigate the role TSC2 binding domain and its binding 











Figure 2. Representation of regular TSC2-Rheb activity. TSC2 
dephosphorylates Rheb and Rheb-GDP decreases cell signaling. TSC2-
218 predicted structure from I-TASSER, Rheb-GDP (1XTQ.pdb), Rheb-
GTP (1XTS.pdb)(33,34,39) 
Figure 3. Representation of TSC2 N119K-Rheb activity. TSC2 could 
cause weak or no interaction and that leads to abnormal cell signaling. 
TSC2-218 N119K predicted structure from I-TASSER, Rheb-GDP 






Materials and methods 
2.1 Mutagenesis experiment  
All plasmids were isolated using the QIAprep Spin Miniprep Kit protocol. First, 30 ml 
Luria-Bertani (LB) media, 30 l ampicillin, and 500 l glycerol stock were mixed in a 50ml tube 
and incubated overnight in a 37C shaker. The next day, the tube was centrifuged for 15 minutes 
at 5000rpm. After that, the supernatant was discarded and the lysate was mixed with the buffers 
as instructed in the kit handbook. The concentration of the plasmid was determined using the 
UV-Vis at 260nm. The plasmid was sent along with the pGEX forward and reverse primers to 
the DNA Sequencing facility at the University of Arkansas for Medical Sciences for sequence 
verification. The primers for the TSC2-218 N119K were created using Quick Change Primer 
Design, an online tool. Several recommendations were taken into consideration when designing 
the primers(35). The primer length was adequate to bind easily at a specific region. The primer 
melting temperature was less than 65C to give the best result and to prevent the secondary 
annealing. In addition, the primer pairs had the same melting temperature to enhance efficiency 
and avoid mispriming. The GC content was acceptable to ensure stable binding between the 
primers and the template(35). The forward and reverse primers were purchased from Integrated 
DNA Technologies. The primers were diluted first with elution buffer and then mixed with the 
PCR reaction buffers. The PCR mix reaction was created by adding 5l of 10X reaction buffer, 
1l of TSC2-218 wild type plasmid, 1l of forward and reverse primers, 1l of dNTP mix, 3l 
of Quick solution, 1l of magnesium chloride (25mM), 39l of sterile MQ water, and 1l of pfu 







Steps Cycle Temperature  Time Cycle 
1 1 95C 1 minute Initial denaturation  
2 18 30 seconds Denaturation  
3 55C 1 minute  Annealing  
4 68C 7 minutes Elongation  
 
 
After the cycle was completed, 5l of the product was set aside and labeled as 
undigested. 1.5l of the restriction enzyme DpnI was added to the PCR product. The digested 
and undigested PCR amplified products, in addition to the DNA ladder, were loaded and run into 
the agarose gel. The gel image was taken using a transilluminator. After that, the DNA was 
transformed on NEB 5-alpha competent cells, which are highly efficient for transformation and 
isolation purposes. N119K DNA was added to the competent cells and incubated in ice for 30 
minutes. The sample was heated and cooled for two minutes then added to 1ml of LB media. The 
sample was then incubated in the shaker at 37C for two hours and later centrifuged for 10 
minutes. 800l was discarded and 100l was plated into an LB agar inside the hood. The plate 
was incubated overnight at 37C. Over the next day, 2-3 colonies were removed for plasmid 
isolation. Plasmid isolation was performed to confirm the variant’s sequence. Once confirmed, 
the DNA was transformed into BL21 (DE3) cells, which are highly efficient for protein 
expression and harvesting.   
Table 1: PCR Cycles conditions 






2.2 Growth, harvesting, and purification  
2.2A TSC2-218 Wild Type 
A previous student performed test expressions and produced a standard protocol for 
obtaining TSC2-218 wild type, which was applied in this study(30). Plasmid isolation was 
performed on BL21 (DE3), and colonies were transferred to 15mL LB media and 15l ampicillin 
for a small-scale expression. Ampicillin was added to ensure that only bacteria that have 
incorporated the antibiotic resistant gene successfully in the plasmid will grow in the presence of 
the antibiotic. The mix was allowed to grow for 3-5 hours at 37C in the shaker. After 
incubation, the tube was added to 100ml LB media with 100l ampicillin and allowed to grow 
overnight in the 37C shaker. The next day, the mixture was added to 1.5L LB media and 750l 
ampicillin (large-scale expression). The optical density (OD) reading was taken using the UV-
Vis at 600nm every hour until the reading reached to 0.8-1.0. This range is where the bacteria 
reach the mid-log phase (cells are set to produce the maximum number of proteins). Then, 
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to maximize the protein yield and was 
incubated for 5 hours at 25C. After centrifugation, the precipitate was collected and 
resuspended with 10mM 1x phosphate buffered saline (PBS). After a 2nd centrifugation the 
collected pellet was either stored at -80C or used directly for the purification. For the 
purification, the 1.5L pellet was thawed in ice and resuspended in the lysis buffer, which is 45ml 
10mM 1x PBS buffer, 25mg lysozyme, Halt protease inhibitor cocktail, DNAse, and 25mM 
phenylmethane sulfonyl fluoride (PMSF). Sonication was applied to lyse the cell and free the 
proteins. The lysed cells were centrifuged at 29,000 rpm for 20 minutes and the supernatant was 
loaded on the fast protein liquid chromatography (FPLC) machine after it was filtered. For 






glutathione pH8 were prepared, respectively. A glutathione S transferase (GST-tag) column was 
used to purify the protein. The column was cleaned first with guindium hydrochloride and 
guindium was removed with water. FPLC purification was accomplished in three steps. First, the 
column was equilibrated with the binding buffer. The target protein was then bound to the 
column through the tag and unbounded proteins were eluted. The last step was elution, where an 
isocratic gradient of the elution buffer was applied to elute the target protein in small fractions. 
The fractions were collected and gel electrophoresis was run in order to confirm the presence of 
the protein in the selected fractions. Once the target band was seen, the protein was dialyzed in 
10mM PBS buffer pH7.3 overnight. The protein concentration was measured and thrombin was 
added accordingly, (where 1 unit thrombin can efficiently cleave 100g protein). The protein and 
thrombin were incubated in a cold room for two hours. The GST-tag was removed by doing 
another FPLC purification. The fractions were collected and was run by SDS-PAGE to see the 
target band. The proteins were collected and dialyzed overnight and then lyophilized for long 
storage at -80C or used directly for experiments.  
TSC2-218 wild type predicted structure was generated based on the amino acid sequence 
of the C-terminal residues using 1-TASSER (an online tool that employs computational 
calculations to produce structure and function predications)36. Chimera was used to analyze the 
predicted structure and highlight the target residue for mutation37.  
2.2B TSC2-218 N119K   
The isolation and purification protocol for TSC2-218 (N119K) was identical to the wild 
type. However, the protein aggregated after dialysis and before GST cleavage. An SDS-PAGE 
was performed to confirm the band of the precipitate and the supernatant. Next, an FPLC 






aggregation. Several trials were attempted to prevent the aggregation including adding 
10%glycerol and 25mM ammonium sulfate, incubating the protein at the cold room and room 
temperature, and exchanging the dialysis buffer each 3 hours. The aggregation was minimized 
when the pH of the dialysis buffer was increased to eight. The following purification steps and 
SDS-PAGE were performed the same as explained in the wild type section. TSC2-218 (N119K) 
predicted structure was generated as explained in the TSC2-218 wild type section.   
2.2C Rheb 
Rheb was overexpressed as a His6-tag fusion protein and purified using a 5ml pre-packed 
Ni2+ column. The protein was tagged on the pET15b vector in Escherichia coli BL21 (DE3) 
strain. All cultures were induced with 0.5mM IPTG when the OD600 reached 0.6-0.8. Culture 
were then incubated for four hours in the shaker at 37C. Centrifugation was applied to harvest 
the cells at 6,000 rpm for 20 minutes at 4C. The pellet was resuspended in 10mM Tris pH 8 and 
was centrifuged at 5,000 rpm for 15 minutes at 4C. For purification, the pellet was resuspended 
in the lysis buffer, which has Tris/HCl Ni2+ binding (pH 8.0, 01 M MgCl2, 0.1 M NaCl, 0.05 Tris 
and 0.04 M imidazole) 45 mg lysozyme, halt protease, DNAse, and 25M PMSF. The cells were 
completely lysed using a sonicator with 12 short burst of 10 seconds followed by rest for 10 
seconds and cooling for 4 minutes. Centrifugation was applied at 19,000rpm for 20 minutes at 
4C to remove cell debris. The supernatant was filtered and loaded on the FPLC machine to 
separate the target protein fractions. The binding buffer, Tris/Hcl Ni2+ binding (pH 8.0, 01 M 
MgCl2, 0.1 M NaCl, 0.05 Tris and 0.04 M imidazole), and the elution buffer, Tris/Hcl Ni2+ 
binding (pH 8.0, 01 M MgCl2, 0.1 M NaCl, 0.05 Tris and 0.25 M imidazole), were filtered 
before the purification was applied. The purification procedure was the same as stated before, but 






was run to confirm the band size and purity. The collected protein fractions were dialyzed in 0.1 
M NaCl, 0.02 M Tris, 0.01 M MgCl2 pH8 at 4C for overnight. For active Rheb, Rheb was 
nucleotide exchanged using a desalting PD-10 column. Rheb was incubated with 5mM GTP 
analog and 5mM EDTA for 1 hour at the cold room. The column was equilibrated with the 
binding buffer and then the protein was loaded into the column. The collected fractions were 
color tested by adding Bradford assay.10mM MgCl2 was added to the dark blue color fractions. 
The protein could either be lyophilized or used directly for experiments.  
2.3 Circular dichroism 
Circular dichroism (CD) was carried out using a JASCO J-1500 CD Spectrometer to 
assess the protein secondary structure changes involving all TSC2-218 constructs, as well as 
protein interactions with Rheb were carried out. The Spectra Measurement program was used to 
collect the spectra in triplicate(38). Purified proteins at a concentration of 0.1 mg/ml were 
suspended in 10mM 1x PBS buffer at pH7.3. The CD spectra were scanned between 250 and 190 
nm in the 0.2 mm pathlength quartz spectrophotometer cell. The parameters were set to measure 
the spectra at 50 nm/min with accumulation of two scans for each spectrum, a spectral bandwidth 
of 1 nm, and a response time of 8 second. The data were expressed in molar ellipticity values 




                                         (Eq.1) 
where A is the absorbance, C is the concentration in g/L, M is the molecular weight in g/mol, 
and L is the pathlegnth of cell in cm. The final protein spectra were obtained by subtracting the 






CD difference spectra measurements were characterized by measuring the spectra of the 
incubated TSC2-218 wild type and TSC2-218(N119K) with the ligand protein, Rheb. The ligand 
spectra were subtracted from the ligand + protein spectra and the data were plotted using Origin.  
2.4 Thermal denaturation:  
Thermal denaturation experiments were performed using spectroscopy, as described 
earlier. The concentrations of the purified proteins were 0.2 mg/ml and they were suspended in 
10 mM 1x PBS at pH7.3 in 0.2 mm pathlength quartz spectrophotometer cell. The temperature 
was set from 25 to 90 C in steps of 0.5 C/min and wavelength ranging from 190 to 250 nm. 
The midpoint temperature was monitored at a wavelength of 211 nm and was determined from 
the experimental sigmoid curve using Origin. Buffer spectra were measured and subtracted from 
each spectrum. Results were converted to molar ellipticity according to equation 1, and fraction 




                                           (Eq.2) 
where Fd is the fraction of denatured protein, MEx is the absorbance, MEi is the fraction of the 
native protein, and MEF is the fraction of the unfolded protein. Curves were created by plotting 
the fraction of denatured protein as a function of temperature.  
2.5 Chemical denaturation  
Chemical denaturation measurements were performed using CD also with 8M urea at 25C. 
CD Spectroscopy was used because it is convenient and sensitive to protein 2 structure changes. 
The machine has an automatic titration function that spontaneously subtracts the protein of 
interest from the cuvette, and adds a specific quantity of denatured protein in high concentrations 
of urea. Then, the fluorescence measurement takes place after incubating the sample at a 






program, and the spectra were recorded in triplicate. 0.2 mg/ml of purified protein in 10mM 
phosphate buffer at pH 7.3 was titrated with urea in a 10mm pathlegnth cuvette. The cuvette has 
a stirrer bar in order to mix the solution with the titrant. Protein denaturation was monitored by 
measuring the fluorescence changes in the near-UV region (300-400 nm) with slits widths of 3 
nm. Raw ellipticity values were converted to molar ellipticity using equation 1, and fractional 
denaturation was calculated according to equation 2 with applying fluorescence intensity instead 
of molar ellipticity intensity. Denaturation fractions were plotted as a function of urea 


















Results and discussion 
3.1 Mutagenesis Study  
The site directed mutagenesis was performed successfully and the DNA sequence was 
confirmed. To create the N119K construct, asparagine was replaced by lysing using the 
following primers: Forward: CGCGGTGGACCCGTTTCTGAAACACAGGTA  
Reverse: GCGCCACCTGGGCAAAGACTTTGTGTCCAT. Successful PCR amplification is 
shown in Figure 4. The bands in the first well are related to the molecular weight marker. The 
band in the lane 2 shows the undigested sample while the band in lane 3 indicates the amplified 
N119K. The amplified plasmid was transformed in two bacterial cell lines for isolation and 
expression. The transformation on BL21 (DE3) cells produced a good yield of colonies and it is 
shown in Figure 5.   
3.2 Growth, harvesting, and purification:  
TSC2 wild type or variant were grown and expressed as GST-tagged proteins. The 
proteins were purified using the FPLC machine—as described in the previous section—and 
SDS-PAGE was applied to ensure the proteins’ purity. Figure 6 shows the TSC2-GST protein 
band after the first GST-tag chromatography purification. Lane 2 shows the lysate, which was 
collected before loading the sample into the machine.  Lane 3 represents the flow through 
(unbound protein), which was collected after the protein binding on the column. It was expected 
that the protein band would be visible in the lysate and not in the flow through. This was 
confirmed, which indicated that the tagged protein was bound to the column. Lane 4, 5, 6 and 7 
represent the GST-protein elution fractions. The band at 51 KDa is a combination of GST 26.9 
KDa and TSC2-218 24 KDa as expected (39). Figure 7a shows the SDS-PAGE after the second 






presence of two bands at 25 KDa indicate that the protein is cleaved from the GST tag. Lane 
3,4,5, and 6 represent the pure TS2-218 fractions. The last two lanes show the GST bands at 25 
KDa. The fractions were collected, dialyzed, and concentrated using a 10kDa MW cutoff 
Millipore centrifugal concentrator. The concentrated TSC2-218 band is shown in Figure 7b.  
 
 
Figure 6: SDS-PAGE of the wild type protein after the first 
affinity purification. Lane 1 is the molecular weight marker. 
Lane 2 is the lysate. Lane 3 is the flow through. Lanes 4,5, 6, 








For the TSC2-218 (N119K), Figure 8 shows the SDS-PAGE after the first 
chromatography purification. The TSC2-218 N119K-GST band is shown in the lysate and, with 
very low concentration, in the flow through, which indicates that most of the protein attached to 
the GST-column. Lane 5,6, 7, and 8 represent the TSC2-218 N119K-GST fractions. Another 
SDS-PAGE was performed to analyze the aggregation of the variant after the first successful 
purification and it is presented in Figure 9. Lane 2 shows the presence of intact N119K-GST 
sample before adding thrombin. Lane 3 represents the aggregation sample and it shows two 
bands: a higher intensity band at 51 KDa and a lower intensity band at 25 KDa. The higher 
intensity band indicates that most of the N119K-GST aggregated before cleavage occurrence. 
Figure 7a: SDS-PAGE of the wild type protein after the 
second affinity purification. Lane 1 is the molecular weight 
marker. Lane 2 is the cleaved protein. Lanes 5, 6,7,8, and 9 
are different fractions of the TSC2-218. Lane 10 and 11 are 
GST bands.  
Figure 7b: SDS-
PAGE of the 
concentrated TSC2-
218 WT. Lane 1 is 
the molecular weight 
marker. Lane 2 and 3 






Lane 4 contains the supernatant sample and shows a presence of a thick band at 25 KDa, which 
could be related to free GST or cleaved N119K. Another round of affinity chromatography 
purification was performed for the supernatant sample to determine if the band at 25 KDa is free 
GST or cleaved N119K, which confirmed the band was related to GST and demonstrated that the 
variant is more susceptible to aggregate. These observations led to test different dialysis 
environments in order to minimize the aggregation. Dialysis of the variant in 10mM 1x PBS pH 
8 achieved the lowest aggregation occurrence. Figure 10a shows the SDS-PAGE after the second 
chromatography purification was applied. Lane 2 and 3 shows the cleaved N119k, and lanes 8-12 
show the pure N119K fractions. The pooled protein fractions were dialyzed and concentrated 
using the same method as the wild type. The TSC2-218 (N119K) concentrated band is shown in 






Figure 8: SDS-PAGE of TSC2-218-N119K after the first 
affinity purification. Lane 1 is the molecular weight marker. 
Lane 2 is the lysate. Lane 3 is the flow through. Lanes 5, 6, 7, 













Figure 9: SDS-PAGE of the TSC2-218-
N119K aggregation. Lane 1 is the molecular 
weight marker. Lane 2 is N119k-GST. Lane 
3 is the aggregation. Lane 4 is the 
supernatant.  
Figure 10b: SDS-PAGE of the 
concentrated TSC2-218 
N119K. Lane 1 is the 
molecular weight marker. 
Lane 2, 3, 4 are protein 
fractions.   
Figure 10a: SDS-PAGE of the N119K after the second affinity 
purification. Lane 1 is the molecular weight marker. Lane 2 and 
3 are the cleaved protein. Lanes 8 - 13 are different fractions of 






The Rheb GTPase domain was expressed as a His6-tagged and purified as described in 
the previous section. An SDS-PAGE was applied to confirm the purity of the pooled fraction, 
which is shown in Figure 8. The presence of a very light band in the flow through indicated a 
successful attachment of the protein into the nickel column. The protein eluted at increasing 
concentration of imidazole and the bands were shown in Figure 11. 
 
Figure 11: SDS-PAGE of Rheb after the affinity 
purification. Lane 1 is the molecular weight marker. 
Lane 2 is the lysate. Lane 3 is the flow through. 






3.3 Circular dichroism  
To facilitate further analysis of the proteins’ structural features, CD measurements were 
applied. CD spectra were obtained by monitoring the peaks at 190-250 nm and were compared to 
the typical spectra. Figure 12 shows the spectra of the wild type and the variant with two 
negative peaks at 211 nm. This observation confirmed that both proteins are composed mainly 
of alpha-helix structures. However, there was a slight difference between the spectra of the wild 
type and the variant, which suggested that the introduced mutation might have a slight effect on 
the protein structure. 
 
Figure 12: Native CD spectra of 
the wild type and the variant. The 
introduced signal-point mutation 
caused a slight change in the 
protein’s secondary structure. The 







Difference spectra were recorded to visualize the effect of Rheb binding on the secondary 
structure in the TSC2-218 wild type and TSC2-218 (N119K). The CD spectra of the proteins 
were recorded in the far UV region (190-250 nm) (Figure 13a) The spectra were normalized and 
labelled in different colors: Blue is the unbound protein, orange is the protein bound to Rheb, and 
yellow is the bound protein subtracted from Rheb mathematically. For the TSC2-218 wild type, 
there was a change in the spectra for the unbound protein and the bound protein, and that 
indicated the conformational change of TSC2-128 wild type occurred because of Rheb binding. 
In addition, previous data highlight the fact that TSC2-218 binds to Rheb causing GTP 
hydrolysis using other applications such as GTP hydrolysis and NMR(29,30). On the other hand, 
Figure 13b shows the difference spectra for the variant and displays a smaller difference between 
the bound and unbound TSC2-218 N119K than the TSC2-218 wild type. This finding signifies 
that the mutation causes a slight change on the protein secondary structure which may correlates 
with the binding between TSC2-218 (N119K) and Rheb. Further investigations using other 




Figure 13a: CD Spectra of the wild type, wild type with Rheb, wild type without 
Rheb. Difference CD spectra of the wild type show a significant difference when 
it is bound to Rheb compared to unbound protein. The wild type is blue, wild 













Figure 13b: CD Spectra of the variant, variant with Rheb, and variant 
without Rheb\. Difference CD spectrua of the variant show a minor 
difference when it is bound to Rheb compared to unbound one. The 
variant is blue, variant with Rheb is orange, and variant with Rheb 






3.4 Thermal denaturation: 
To assess the thermal stability of the wild type and the variant, thermal denaturation 
experiments were performed. Molar ellipticity values were monitored at 208 nm, which 
displayed the highest absolute values as can be seen in the negative peaks (Figure12). The 
melting temperatures of both proteins were calculated using the protein fraction denatured 
equation. Figure 14 presents the curves for thermal denaturation and shows the melting 
temperatures (Tm). The data shows that the calculated Tm for the wild type is 62° and for the 
variant is 64°. The similarity of the proteins’ melting temperatures implies that the 
thermodynamic stability of the wild type was not significantly changed and reflects the slight 
difference shown in the CD spectra. As a result, the single point mutation N119K exhibits a low  
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62° 64°   
Figure 14: Thermal denaturation curves of the TSC2-218 
wild type and variant. The introduced mutation did not 
change the melting temperature significantly. The wild 






3.5 Chemical denaturation: 
Chemical denaturation was performed to measure the effect of the mutation on the 
protein stability under specific conditions. The stability measurements lay the groundwork for 
the variant characterization. The denaturation curves were generated by titrating increasing 
concentrations of 8 Molar (M) urea at 25°C. Urea disrupts the protein’s secondary structure by 
breaking down the hydrogen bonds and allowing the hydrogen bonds binding to salts in order to 
stabilize the denatured protein. The intensity values were recorded by monitoring the 
fluorescence spectra at 340 nm (near UV region). As shown in Figure 12, at low concentration, 
the proteins barely started to unfold and they completely were denatured at less than 8 M 
concentration of urea. Both TSC2 wild type and variant contain two tryptophan residues (a major 
intrinsic flour) in the hydrophobic core and, as the urea concentration increased, the proteins 
started to unfold and that exposed the tryptophan residues to the surface, which showed more 
fluorescence intensity. The urea concentration, where the protein is half-unfolded (Cm), was 
calculated to be at 3.7 M for the TSC2-218 wild type and at 3.5 M urea for the variant N119K 
(Figure 15). This experiment revealed that both the wild type and the variant unfolded at the 




































WildType Variant    
3.7 3.5   
Figure 15: Chemical denaturation curves of the TSC2-
218 wild type and variant. The introduced mutation did 
not alter the chemical stability significantly. The wild 






Conclusion and future perspectives  
4.1 Conclusion  
The mTOR pathway is triggered by the active state of Rheb (Rheb-GTP). The activity of 
Rheb is partially controlled by TSC2 GAP domain that dephosphorylates Rheb-GTP and 
produces Rheb-GDP. Limited progress has been made in the investigation of TSC2-Rheb 
interaction, therefore, the molecular characterization of this interaction is not completely 
understood. In the study reported here, a single point mutation (N119K) in the GAP catalytic 
region is created to examine the importance of the asparagine residue. Several experiments were 
performed to study TSC2-218 N119K stability and interaction with Rheb. 
The study of the structural properties provides insight into the variant activity. The 
thermal and chemical stability results strongly support that the variant could behave similarly to 
the wild type and that correlates to the similarity of the CD spectra. Although this study shows 
that Asn1643Lys mutation causes a minor change on the secondary structure in the presence of 
Rheb, an investigation of Rheb GTP hydrolysis using a quantitative technique is essential to 
analyze the variant GAP activity.  
As stated before, it is believed that TSC2 GAP domain uses the Asn-thumb mechanism to 
stimulate Rheb GTP, which signifies the importance of this residue for catalysis(31). A previous 
study shows the effect of Asn1643 mutation to several residues (including Ala, Asp, Gln, Arg, 
and Ile) on the GTPase activity of Rheb by obtaining 1H, 15N-HSQC-NMR spectra(32). These 
mutations cause inhibition of the GAP activity towards Rheb, which underlie the cause of TSC 
disease. The dysfunction of the mutated GAP domain values the importance of the carboxylic-
amide group(32). Likewise, mutation of the residues in the GAP catalytic region of RAP1 GAP 






because of an absence or a weak binding. The investigation of the mutations binding will fill the 
gap in understanding the TSC2-Rheb interaction. Based on the other mutational studies, it is 
expected that Asn1643Lys might lose the activity to hydrolyze Rheb due it the absence of the 
carboxylic-amide group. However, this conclusion needs to be confirmed by applying additional 
experimentations.  
4.2 Future perspectives: 
This project has established the foundation of N119K characterization. Further studies of 
the N119K using nuclear magnetic resonance spectroscopy (NMR), 15N Heteronuclear single 
quantum coherence (HSQC), will provide more knowledge about the residues that are 
responsible for the conformational changes. In addition, GTP hydrolysis will help to assess the 
ability of the variant to dephosphorylate Rheb and provide a quantitative measurement. For 
TSC2-218 N119K and Rheb binding, isothermal titration calorimetry (ITC) will be performed to 
examine the thermodynamic profile and the binding affinity to Rheb. A detailed study of the 
N119K variant will uncover more information about the variant’s structure, activity and 
interaction.     
The long-term objective is to provide more understanding into how TSC2 stimulates GTP 
hydrolysis of Rheb and how TSC2 regulates the mTOR pathway. This project’s data and other 
TSC2 mutations findings will underline the causes of TSC disease. Moreover, the information 
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